In the PD-L1-positive high potential group, up to 71.43% of tumors with lymph node metastasis and an SUVmean ≥ 2.9 were found to be PD-L1 positive. The gene discussed is CD274; the disease is metastatic malignant neoplasm in the lymph nodes.